AstraZeneca PLC (AZN)

AstraZeneca Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	5,840	6,166	6,329	7,832	5,369
Short-Term Investments	122	239	69	160	849
Cash & Cash Equivalents	5,962	6,405	6,398	7,992	6,218
Cash Growth	-6.92%	0.11%	-19.94%	28.53%	9.47%
Receivables	12,929	11,356	10,539	7,742	6,501
Inventory	5,424	4,699	8,983	4,024	3,193
Other Current Assets	739	133	324	-214	-349
Total Current Assets	25,054	22,593	26,244	19,544	15,563
Property, Plant & Equipment	10,502	9,449	10,171	8,917	8,335
Long-Term Investments	1,677	1,142	1,237	1,147	1,459
Goodwill and Intangibles	58,137	59,127	62,489	32,792	32,501
Other Long-Term Assets	5,749	4,172	5,222	4,329	3,519
Total Long-Term Assets	76,065	73,890	79,119	47,185	45,814
Total Assets	101,119	96,483	105,363	66,729	61,377
Accounts Payable	25,034	23,310	23,871	21,869	20,278
Current Debt	5,400	5,542	1,893	2,386	2,010
Other Current Liabilities	108	-2,559	-3,170	-3,948	-4,171
Total Current Liabilities	30,542	26,293	22,594	20,307	18,117
Long-Term Debt	23,222	23,690	28,888	17,994	16,217
Other Long-Term Liabilities	8,189	9,442	14,594	12,790	12,447
Total Long-Term Liabilities	31,411	33,132	43,482	30,784	28,664
Total Liabilities	61,953	59,425	66,076	51,091	46,781
Total Debt	28,622	29,232	30,781	20,380	18,227
Debt Growth	-2.09%	-5.03%	51.04%	11.81%	-4.64%
Retained Earnings	1,502	-574	1,710	5,299	2,812
Shareholders' Equity	39,143	37,037	39,268	15,622	13,127
Net Cash / Debt	-22,660	-22,827	-24,383	-12,388	-12,009
Net Cash Per Share	-14.51	-14.63	-17.09	-9.43	-9.23
Working Capital	-5,488	-3,700	3,650	-763	-2,554
Book Value Per Share	12.63	11.96	13.85	5.95	5.04

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).